These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16513679)

  • 1. Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model.
    Lin X; Yu Y; Zhao H; Zhang Y; Manela J; Tonetti DA
    Carcinogenesis; 2006 Aug; 27(8):1538-46. PubMed ID: 16513679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
    Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
    Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
    Perez White B; Molloy ME; Zhao H; Zhang Y; Tonetti DA
    Mol Cancer; 2013 May; 12():34. PubMed ID: 23634843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.
    Tonetti DA; Chisamore MJ; Grdina W; Schurz H; Jordan VC
    Br J Cancer; 2000 Sep; 83(6):782-91. PubMed ID: 10952784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
    Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC
    Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
    Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
    Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.
    Park WC; Liu H; Macgregor Schafer J; Jordan VC
    Int J Oncol; 2005 Nov; 27(5):1459-66. PubMed ID: 16211243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
    Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
    Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas JC; Lidereau R; Cohen PA
    Endocr Relat Cancer; 2005 Mar; 12(1):75-92. PubMed ID: 15788640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.
    Nabha SM; Glaros S; Hong M; Lykkesfeldt AE; Schiff R; Osborne K; Reddy KB
    Oncogene; 2005 Apr; 24(19):3166-76. PubMed ID: 15735693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
    Chen J; Hui E; Ip T; Thompson LU
    Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta.
    Haughian JM; Jackson TA; Koterwas DM; Bradford AP
    Endocr Relat Cancer; 2006 Dec; 13(4):1251-67. PubMed ID: 17158769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.
    Zhang Y; Zhao H; Asztalos S; Chisamore M; Sitabkhan Y; Tonetti DA
    Mol Cancer Res; 2009 Apr; 7(4):498-510. PubMed ID: 19372579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
    Lu M; Miller KD; Gokmen-Polar Y; Jeng MH; Kinch MS
    Cancer Res; 2003 Jun; 63(12):3425-9. PubMed ID: 12810680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.